Economic burden of post-acute myocardial infarction heart failure in the United Kingdom
- PMID: 15921811
- DOI: 10.1016/j.ejheart.2004.10.020
Economic burden of post-acute myocardial infarction heart failure in the United Kingdom
Abstract
Congestive heart failure (CHF) is a major cause of morbidity and mortality. This study was carried out to quantify the burden of CHF, subsequent to acute myocardial infarction (AMI), from the perspective of the UK National Health Service (NHS). A systematic literature review of publications since 1990 was carried out on the economic burden of heart failure. The economic burden of post-AMI heart failure in the UK for the year 2000 was estimated for two scenarios: (1) Base-case estimate (post-AMI heart failure accounts for 20% of heart failure cases): Direct healthcare costs of pound 125-181 million (approx. 0.4% of total NHS spend) and nursing home costs of pound 27 million; (2) Upper estimate (post-AMI heart failure accounts for 50% of the total): Direct healthcare costs of pound 313-453 million (approx 1.0% of total NHS spend) and nursing home costs of pound 68 million. In conclusion, post-AMI heart failure imposes a significant direct economic burden on the UK.
Similar articles
-
Evaluation of the ventricular assist device programme in the UK.Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480. Health Technol Assess. 2006. PMID: 17134596
-
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450. Health Technol Assess. 2005. PMID: 16303098
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.Health Technol Assess. 2000;4(23):1-153. Health Technol Assess. 2000. PMID: 11074393
-
A systematic review and economic evaluation of statins for the prevention of coronary events.Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140. Health Technol Assess. 2007. PMID: 17408535
Cited by
-
Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection.J Adv Res. 2020 Sep 28;29:33-44. doi: 10.1016/j.jare.2020.09.007. eCollection 2021 Mar. J Adv Res. 2020. PMID: 33842003 Free PMC article.
-
Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.Respir Res. 2019 Oct 10;20(1):215. doi: 10.1186/s12931-019-1179-7. Respir Res. 2019. PMID: 31601216 Free PMC article.
-
Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension.Pharmacoeconomics. 2006;24(12):1249-72. doi: 10.2165/00019053-200624120-00008. Pharmacoeconomics. 2006. PMID: 17129078 Review.
-
Impaired Diastolic Function Predicts Improved Ischemic Myocardial Flow by Mechanical Left Ventricular Unloading in a Swine Model of Ischemic Heart Failure.Front Cardiovasc Med. 2022 Jan 12;8:795322. doi: 10.3389/fcvm.2021.795322. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35097014 Free PMC article.
-
Effect of wenxin granule on ventricular remodeling and myocardial apoptosis in rats with myocardial infarction.Evid Based Complement Alternat Med. 2013;2013:967986. doi: 10.1155/2013/967986. Epub 2013 Aug 13. Evid Based Complement Alternat Med. 2013. PMID: 23997803 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical